News | March 30, 2009

German, Swiss Hospitals Treating ‘Difficult’ Cases with RapidArc

March 30, 2009 - Gottingen University Hospital in Germany and Zurich University Hospital in Switzerland are amongst the earliest implementers of the RapidArc system from Varian Medical Systems and have commenced treatments for complex cancers, including head and neck tumors.

Varian’s RapidArc delivers treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided IMRT reportedly two to eight times faster than is possible with conventional IMRT.

Doctors at Gottingen University Hospital are focusing early RapidArc treatments on what they describe as 'difficult' cases. "Today we are treating a nasopharyngeal cancer patient with a boost of RapidArc because we could not create an acceptable IMRT plan, so there are clearly some patients for whom RapidArc offers a more appropriate treatment," says Dr. Hilke Vorwerk.

Dr. Vorwerk said they will begin RapidArc treatments for patients with head and neck tumors and prostate cancer. "Our experience so far is that in most cases RapidArc is as good as conventional IMRT and in some cases superior, as well as being considerably faster, which is important for patient comfort but also for treatment precision as there is less patient motion," she said. Gottingen University Hospital has the only radiotherapy department south of Niedersachen and treats up to 2,000 new cancer patients each year.

"Up to now we have not had a major problem with waiting lists, but cancer referrals have increased by 150 percent in the last two years, so faster treatments will give us extra capacity to meet this growing demand," added Dr. Vorwerk. "In addition, more patients will be able to receive the most modern treatments available."

At Zurich University Hospital, a 55-year-old patient with a recurrence of a previously-operated tonsil cancer received RapidArc radiotherapy treatment from Dr. Gabriela Studer and her team. "Our first RapidArc treatment involved a difficult plan because we were treating lymph node metastases and we were very impressed by the speed of the new treatment," says Dr. Studer.

Zurich University Hospital and Gottingen University Hospital are among more than 70 institutions in the world with the new RapidArc treatment capability for image-guided IMRT. Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

For more information: www.varian.com

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res